0000827054-25-000183
SEC filingNet sales fell 2% in Q3 FY26 to $1.14B; gross margin compressed to 55.9% amid inventory correction; analog growth a bright spot.
In the three months ended September 30, 2025, net sales declined 2.0% year-over-year to $1.14B, reflecting ongoing customer inventory destocking and adverse economic conditions. Gross profit fell to $637.9M (55.9% of sales) from $668.5M (57.4%) in the prior year, pressured by unfavorable product and geographic mix, $11M in unabsorbed capacity charges from underutilized fabs, and lower licensing revenue. Operating income dropped to $88.95M (7.8% margin) compared to $146.6M (12.6%) a year ago, as R&D and SG&A expenses rose both in absolute dollars and as a percentage of sales. Net income for the first half of fiscal 2026 was $23.1M, down 89% from $207.7M in the prior year period, impacted by lower revenue and restructuring charges.
Mixed-signal microcontrollers, the largest product line (51.3% of Q3 sales), saw revenue decline 1.7% YoY to $584.5M, as customers maintained high inventory levels. Analog products posted a 10.1% increase to $321.5M (28.2% of sales), driven by customers who had worked through excess stock and began reordering. The 'Other' category (FPGA, licensing, memory, etc.) fell 15.4% to $234.4M, reflecting broad-based weakness. Geographically, sales in the Americas declined 8.5% in Q3, while Europe grew 5.7% and Asia was flat. Distributor inventory days decreased to 27 from 33 at March 2025, signaling progress in the recovery plan.
Management indicated that the inventory correction is abating, with sequential sales improvement in the first half of fiscal 2026 compared to Q4 FY25. Factory expansion remains paused, and capital expenditures are expected to be at or below $100M over the next 12 months. The company continues to focus on reducing inventory (199 days at September 2025, down from 251) and improving operational efficiency. No specific revenue or earnings guidance was provided, but the MD&A notes that future gross margins will fluctuate with capacity utilization, product mix, and competitive conditions.
As of September 30, 2025, Microchip held $236.8 million in cash and cash equivalents, a significant decrease from $771.7 million at March 31, 2025. Total debt stood at $5,375.9 million (net of discounts and issuance costs), down from $5,630.4 million at the prior fiscal year-end. The company had $1.12 billion of commercial paper outstanding at a weighted-average interest rate of 4.47%, up from $175.0 million at March 31, 2025. Shareholders' equity was $6,695.5 million, compared to $7,078.3 million at March 31, 2025. Inventory decreased to $1,095.3 million from $1,293.5 million, reflecting a $201.0 million reduction in inventories during the six-month period.
Total purchase commitments as of September 30, 2025 were $409.1 million, primarily consisting of wafer purchase obligations and manufacturing supply capacity reservation commitments. The timing of these commitments is: $195.4 million in fiscal 2026, $80.3 million in fiscal 2027, $71.0 million in fiscal 2028, $16.7 million in fiscal 2029, $9.6 million in fiscal 2030, and $36.1 million thereafter. Deferred revenue totaled $385.8 million, of which $291.5 million is cash collected under long-term supply agreements (LTSAs) with terms typically ranging from three to five years. The company also disclosed indemnification contingencies of up to $197.0 million under technology license agreements.
During the six months ended September 30, 2025, Microchip did not repurchase any common stock; approximately $1.56 billion remained available under the existing repurchase program. The company paid $245.8 million in common stock dividends ($0.455 per share quarterly) and $52.9 million in Series A Preferred Stock dividends. Debt activity included $1,588.4 million in commercial paper issuances and $650.1 million in repayments, along with the repayment of $1,200.0 million of 4.250% 2025 Notes. Capital expenditures were $54.4 million, representing 4.8% of net sales.
The company operates two segments: semiconductor products and technology licensing. For the three months ended September 30, 2025, semiconductor products generated net sales of $1,108.0 million and gross profit of $605.5 million, compared to $1,125.0 million and $629.7 million in the prior-year period. Technology licensing contributed $32.4 million in net sales and gross profit, down from $38.8 million a year ago. The CODM evaluates segment performance using gross profit; operating expenses are not allocated. Net sales by product line included mixed-signal microcontrollers ($584.5 million), analog ($321.5 million), and other ($234.4 million) for the quarter. By customer type, distributors accounted for $515.9 million, direct customers $592.1 million, and licensees $32.4 million.